疼痛管理装置の世界市場：神経刺激装置、SCS（脊髄刺激療法）、TENS、ラジオ波焼灼療法、注入ポンプ...市場調査レポートについてご紹介

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Markets Covered
1.4.1 Years Considered for the Study
1.5 Currency
1.6 Stakeholders

2 Research Methodology (Page No. – 20)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.1.2 Primary Research
2.2.1.3 Key Data From Primary Sources
2.3 Market Size Estimation Methodology
2.3.1 Research Methodology: Bottom-Up Approach
2.3.2 Research Methodology: Top-Down Approach
2.4 Research Design
2.5 Market Data Validation and Triangulation
2.6 Assumptions for the Study
2.7 Limitations

3 Executive Summary (Page No. – 28)
3.1 Introduction
3.2 Conclusion

4 Premium Insights (Page No. – 33)
4.1 Global Pain Management Devices Market Overview (2016–2021)
4.2 Geographical Snapshot of the Global Market
4.3 Global Market, By Application and Region (2016)
4.4 Global Market, By Mode of Purchase and Region (2016 vs 2021)

5 Market Overview (Page No. – 37)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Growing Demand for Long-Term Pain Management Among the Geriatric Population
5.3.1.2 Large Patient Population Base
5.3.1.3 Adverse Effects of Pain Medications
5.3.1.4 High Proven Efficacy of Pain Management Devices for the Treatment of Chronic Pain
5.3.1.5 Established Reimbursement Scenario for Spinal Cord Stimulation (SCS) Devices in Developed Countries
5.3.1.6 Development of Novel Pain Management Devices
5.3.2 Restraints
5.3.2.1 Low Awareness About the Availability and Use of Pain Management Devices
5.3.2.2 Shortage of Pain Specialists and Low Number of Pain Clinics in Several Countries
5.3.2.3 Existence of A Gap in Prevalence and Treatment of Pain
5.3.2.4 High Procedural and Purchase Cost of Pain Management Devices
5.3.3 Opportunities
5.3.3.1 Increasing Number of Patients Suffering From Neuropathic Pain
5.3.3.2 Expanding Base of Pain Management Clinics/Centers Across the Globe
5.3.3.3 Strong Product Pipeline for Pain Management Devices
5.3.3.4 Stringent Regulations to Limit Opioid Pain Killer Prescriptions
5.3.4 Challenges
5.3.4.1 Presence of Alternative Therapies for Pain Management
5.3.4.2 Use of Pain Medications as the First Line of Treatment for Pain Management
5.3.4.3 Stringent Regulatory Guidelines Delay the Adoption of Novel Devices

6 Industry Insights (Page No. – 57)
6.1 Introduction
6.2 Industry Trends
6.2.1 Wearable Devices
6.2.2 Consolidation in the Pain Management Devices Market
6.2.3 Rising Popularity of Rechargeable Spinal Cord Stimulators
6.3 Porter’s Five Forces Analysis
6.3.1 Threat of New Entrants
6.3.2 Threat of Substitutes
6.3.3 Bargaining Power of Suppliers
6.3.4 Bargaining Power of Buyers
6.3.5 Intensity of Competitive Rivalry

7 Global Pain Management Devices Market, By Type (Page No. – 62)
7.1 Introduction
7.2 Neurostimulation Devices
7.2.1 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
7.2.1.1 Introduction of Advanced & Wearable TENS Devices
7.2.2 Spinal Cord Stimulation (SCS) Devices
7.2.2.1 Cost Benefits of SCS Over Other Therapies
7.3 Analgesic Infusion Pumps
7.3.1 High Use of Infusion Pumps in Post-Operative Pain Management
7.3.2 Intrathecal Infusion Pumps
7.3.3 External Infusion Pumps
7.4 Ablation Devices
7.4.1 RF Ablation Devices
7.4.2 Cryoablation Devices

8 Global Pain Management Devices Market, By Application (Page No. – 76)
8.1 Introduction
8.2 Neuropathic Pain
8.2.1 High Prevalence of Diseases Associated With Neuropathic Pain
8.3 Cancer Pain
8.4 Facial Pain & Migraine
8.5 Musculoskeletal Pain
8.6 Other Applications

9 Global Pain Management Devices Market, By Mode of Purchase (Page No. – 87)
9.1 Introduction
9.2 Over-The-Counter Pain Management Devices
9.2.1 Otc Pain Management Devices Unfold New Growth Avenues
9.3 Prescription-Based Pain Management Devices

10 Pain Management Devices Market, By Region (Page No. – 92)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.1.1 Rising Geriatric Population in the U.S.
10.2.1.2 Rising Patient Population Base
10.2.1.3 High Demand of Pain Management Devices for the Treatment of Post-Operative Pain
10.2.1.4 Large Number of Ongoing Clinical Trials
10.2.1.5 Favorable Reimbursement Scenario for SCS
10.2.1.6 Stringent Regulatory Policies
10.2.1.7 Lack of Reimbursement for TENS in the U.S.
10.2.2 Canada
10.2.2.1 Reduced Healthcare Spending
10.2.2.2 Rising Prevalence of Chronic Disorders
10.3 Europe
10.3.1 Rising Aging Population in Europe
10.3.2 Huge Patient Population Base
10.3.3 Conferences to Increase Awareness of Pain Management Devices in the European Market
10.3.4 New Product Launches and Product Approvals
10.3.5 Organization of Campaigns to Raise Awareness About Pain Management Approaches
10.3.6 Slow Economic Growth in Europe
10.3.7 Changing Regulatory Policies
10.3.8 Limited Awareness of New Pain Management Approaches
10.3.9 Germany
10.3.9.1 Large Number of Ongoing Clinical Trials
10.3.9.2 Rising Aging Population and Cancer Incidence
10.3.9.3 Favorable Healthcare Reimbursement Scenario
10.3.10 France
10.3.10.1 Rising Adoption of Pain Management Devices Due to Increased Patient Population
10.3.10.2 Availability of Proper Healthcare Facilities, Training, and Reimbursement for Pain Management Therapies
10.3.11 U.K.
10.3.11.1 Large Patient Population Base
10.3.11.2 Rising Healthcare Expenditure
10.3.11.3 Presence of Noteworthy Number of Organizations Related to Pain Management
10.3.11.4 Availability of Funding for Research in Pain Management
10.3.11.5 Government Recommendations Encouraging Use of SCS
10.3.11.6 Safety Issues Related to Infusion Pumps
10.3.11.7 Low Penetration of Pain Management Devices in the Country
10.3.12 RoE
10.3.12.1 Growing Patient Population
10.3.12.2 Rapidly Increasing Aging Population in the Region
10.3.12.3 Growing Preference Towards Home Use Pain Management Devices
10.3.12.4 Key Factors Hampering Market Growth
10.4 Asia-Pacific
10.4.1 Large Patient Population With Cancer, Diabetes, and Chronic Pain
10.4.2 Improving Healthcare Infrastructure in Asian Countries
10.4.3 Japan
10.4.3.1 Growing Patient Base
10.4.3.2 Increase in the Baby Boomer Population
10.4.3.3 Well-Developed Healthcare System
10.4.3.4 Inflow of Advanced Pain Management Devices
10.4.3.5 Rising Government Focus Towards the Development of the Medical Devices Industry
10.4.3.6 Pricing and Reimbursement Challenges for Foreign Suppliers
10.4.4 China
10.4.4.1 Growing Diabetic Population
10.4.4.2 Increasing Disposable Income and Healthcare Spending
10.4.4.3 Extensive Use of Traditional Chinese Medicine (TCM) for Alleviating Pain
10.4.4.4 Uncertain and Changing Regulatory Environment
10.4.5 India
10.4.5.1 Huge Addressable Market
10.4.5.2 Growing Number of Pain Management Centers
10.4.5.3 Rising Focus of Global Players
10.4.5.4 Growing Demand for Pain Management Devices
10.4.5.5 Conferences and Meetings on Neuromodulation & Pain Management in India
10.4.5.6 Rising Government Support
10.4.5.7 High Dependence of Patients on Low-Cost Generic Medicine
10.4.5.8 Key Factors Limiting the Growth of the Indian Market
10.4.6 Rest of Asia-Pacific
10.4.6.1 South Korea Presents Significant Opportunities for Pain Management Devices in Asia
10.4.6.2 Large Number of Conferences in Australia
10.4.6.3 Ongoing Product Innovations in Singapore & Australia
10.5 Rest of the World
10.5.1 Increasing Incidences of Cancer in Latin America
10.5.2 Aging Population
10.5.3 Strict Regulations on Medical Devices in Brazil

11 Competitive Landscape (Page No. – 152)
11.1 Overview
11.2 Market Share Analysis
11.2.1 Key Players in the Market
11.3 Competitive Situation and Trends
11.3.1 New Product Launches and Product Approvals
11.3.2 Agreements, Alliances, and Contracts
11.3.3 Geographical Expansions
11.3.4 Mergers & Acquisitions
11.3.5 Other Developments

12 Company Profiles (Page No. – 160)
(Overview, Financial*, Products & Services, Strategy, and Developments)
12.1 Introduction
12.2 Medtronic PLC
12.3 ST. Jude Medical, Inc.
12.4 Boston Scientific Corporation
12.5 Hospira, Inc. (A Subsidiary of Pfizer Inc.)
12.6 Halyard Health, Inc.
12.7 Smiths Medical
12.8 B. Braun Melsungen AG
12.9 Neurotech Na, Inc. (A Subsidiary of Theragen LLC)
12.10 Becton, Dickinson and Company
12.11 Nevro Corp.

*Details Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 190)
13.1 Discussion Guide
13.2 Introducing Rt: Real-Time Market Intelligence
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Available Customizations
13.5 Related Reports